Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Effects of Glucagon on Lipolysis and Ketogenesis in Normal and Diabetic Men
John E. Liljenquist, … , Oscar B. Crofford, Grant W. Liddle
John E. Liljenquist, … , Oscar B. Crofford, Grant W. Liddle
Published January 1, 1974
Citation Information: J Clin Invest. 1974;53(1):190-197. https://doi.org/10.1172/JCI107537.
View: Text | PDF
Research Article Article has an altmetric score of 14

Effects of Glucagon on Lipolysis and Ketogenesis in Normal and Diabetic Men

  • Text
  • PDF
Abstract

The effect of glucagon (50 ng/kg/min) on arterial glycerol concentration and net splanchnic production of total ketones and glucose was studied after an overnight fast in four normal and five insulin-dependent diabetic men. Brachial artery and hepatic vein catheters were inserted and splanchnic blood flow determined using indocyanine green. The glucagon infusion resulted in a mean circulating plasma level of 4,420 pg/ml.

Authors

John E. Liljenquist, James D. Bomboy, Stephen B. Lewis, Bruce C. Sinclair-Smith, Philip W. Felts, William W. Lacy, Oscar B. Crofford, Grant W. Liddle

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2013 2012 2010 2007 2006 2004 2002 2000 1998 1991 1990 1988 1987 1986 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 Total
Citations: 3 4 4 4 6 5 2 4 5 2 1 1 1 1 1 1 1 3 1 2 1 1 2 1 2 5 2 4 1 2 7 11 6 7 2 106
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (106)

Title and authors Publication Year
Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence
McGlone ER, Bloom SR, Tan TM
The Journal of endocrinology 2024
Integration of metabolic flux with hepatic glucagon signaling and gene expression profiles in the conscious dog
Coate KC, Ramnanan CJ, Smith M, Winnick JJ, Kraft G, Irimia-Dominguez J, Farmer B, Donahue EP, Roach PJ, Cherrington AD, Edgerton DS
American journal of physiology. Endocrinology and metabolism 2024
Incretin and glucagon receptor polypharmacology in chronic kidney disease
McFarlin BE, Duffin KL, Konkar A
American Journal of Physiology - Endocrinology and Metabolism 2024
A physiologic increase in brain glucagon action alters the hepatic gluconeogenic/glycogenolytic ratio but not glucagon’s overall effect on glucose production
Edgerton DS, Kraft G, Smith M, Farmer B, Williams P, Cherrington AD
American journal of physiology. Endocrinology and metabolism 2023
Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes.
Urakami T, Yoshida K, Suzuki J
Internal Medicine 2023
Treatment strategy for children and adolescents with type 2 diabetes-based on ISPAD Clinical Practice Consensus Guidelines 2022.
Urakami T
2023
Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease
Bae J, Lee BW
Biomolecules 2023
Relationship of concomitant anti-diabetic drug administration with sodium-glucose co-transporter 2 inhibitor-related ketosis
C Lin, S Hung, I Chen
J INT MED RES 2022
Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
Mooli RG, Ramakrishnan SK
Frontiers in physiology 2022
Ketones: the double-edged sword of SGLT2 inhibitors?
Lupsa BC, Kibbey RG, Inzucchi SE
Diabetologia 2022
Important Hormones Regulating Lipid Metabolism.
Zhang D, Wei Y, Huang Q, Chen Y, Zeng K, Yang W, Chen J, Chen J
Molecules (Basel, Switzerland) 2022
Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
JA Hoogerland, F Peeks, BS Hijmans, JC Wolters, S Kooijman, T Bos, A Bleeker, TH Dijk, H Wolters, A Gerding, K Eunen, R Havinga, AC Pronk, PC Rensen, G Mithieux, F Rajas, F Kuipers, DJ Reijngoud, TG Derks, MH Oosterveer
Journal of Inherited Metabolic Disease 2021
Adipose tissue lipolysis is regulated by PAQR11 via altering protein stability of phosphodiesterase 4D
M Huang, Y Lin, L Wang, X You, S Wang, J Zhao, M Bai, Z Li, Y Chen
Molecular Metabolism 2021
Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
S Kalra, AG Unnikrishnan, MP Baruah, R Sahay, G Bantwal
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021
Profiling of RNA-binding Proteins Interacting With Glucagon and Adipokinetic Hormone mRNAs.
Ko S, Yeom E, Chun YL, Mun H, Howard-McGuire M, Millison NT, Jung J, Lee KP, Lee C, Lee KS, Delaney JR, Yoon JH
Journal of Lipid and Atherosclerosis 2021
Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis
RJ Perry, D Zhang, MT Guerra, AL Brill, L Goedeke, AR Nasiri, A Rabin-Court, Y Wang, L Peng, S Dufour, Y Zhang, XM Zhang, GM Butrico, K Toussaint, Y Nozaki, GW Cline, KF Petersen, MH Nathanson, BE Ehrlich, GI Shulman
Nature 2020
A compendium of G-protein–coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure
Ceddia RP, Collins S
Clinical science (London, England : 1979) 2020
Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes
MJ Pereira, K Thombare, A Sarsenbayeva, PG Kamble, K Almby, M Lundqvist, JW Eriksson
Molecular and Cellular Endocrinology 2020
Physiologic Mechanisms of Type II Diabetes Mellitus Remission Following Bariatric Surgery: a Meta-analysis and Clinical Implications
SM Russel, V Valle, G Spagni, S Hamilton, T Patel, N Abdukadyrov, Y Dong, A Gangemi
Journal of Gastrointestinal Surgery 2020
Short-term Glucose Lowering Effects of Sodium-glucose Cotransporter 2 Inhibitors Confirmed by Flash Glucose Monitoring in Two Outpatients with Type 1 Diabetes
M HABU, Y OKADA, A KUROZUMI, Y TANAKA
Journal of UOEH 2020
A compendium of G-protein–coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure
RP Ceddia, S Collins
Clinical Science 2020
Glucagon Receptor Signaling and Lipid Metabolism
KD Galsgaard, J Pedersen, FK Knop, JJ Holst, NJ Albrechtsen
Frontiers in physiology 2019
Glucagon Receptor Signaling and Glucagon Resistance
Janah, Kjeldsen, Galsgaard, WS, Stojanovska, Pedersen, Knop, Holst, W Albrechtsen
International journal of molecular sciences 2019
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
T Danne, S Garg, AL Peters, JB Buse, C Mathieu, JH Pettus, CM Alexander, T Battelino, FJ Ampudia-Blasco, BW Bode, B Cariou, KL Close, P Dandona, S Dutta, E Ferrannini, S Fourlanos, G Grunberger, SR Heller, RR Henry, MJ Kurian, JA Kushner, T Oron, CG Parkin, TR Pieber, HW Rodbard, D Schatz, JS Skyler, WV Tamborlane, K Yokote, M Phillip
Diabetes care 2019
Beyond type 2 diabetes: sodium glucose co‐transporter‐inhibition in type 1 diabetes
T Biester, O Kordonouri, T Danne
Diabetes, obesity & metabolism 2019
Metabolic effects of glucagon in humans
MM Adeva-Andany, R Funcasta-Calderón, C Fernández-Fernández, E Castro-Quintela, N Carneiro-Freire
Journal of Clinical & Translational Endocrinology 2019
Au cœur de la cardiomyopathie diabétique: Les souris lipodystrophiques SKO comme modèle d’étude de la glucotoxicité
A Lugat, M Joubert, B Cariou, X Prieur
médecine/sciences 2018
Youth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance
M Cree-Green, JJ Stuppy, J Thurston, BC Bergman, GV Coe, AD Baumgartner, S Bacon, A Scherzinger, L Pyle, KJ Nadeau
The Journal of clinical endocrinology and metabolism 2018
Glucagon’s effect on liver protein metabolism in vivo
G Kraft, KC Coate, JJ Winnick, D Dardevet, EP Donahue, AD Cherrington, PE Williams, MC Moore
American journal of physiology. Endocrinology and metabolism 2017
Lipid metabolism in patients with chronic hyperglycemia after an episode of acute pancreatitis
NA Gillies, SA Pendharkar, RG Singh, VM Asrani, MS Petrov
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017
Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition
SE Thiessen, S Derde, I Derese, T Dufour, CA Vega, L Langouche, C Goossens, N Peersman, P Vermeersch, SV Perre, JJ Holst, PJ Wouters, I Vanhorebeek, GV Berghe
American journal of respiratory and critical care medicine 2017
The New Biology and Pharmacology of Glucagon
TD Müller, B Finan, C Clemmensen, RD DiMarchi, MH Tschöp
Physiological reviews 2017
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: FGF21 AS AN EMERGING THERAPEUTIC TARGET FOR T2DM
WY So, PS Leung
Medicinal Research Reviews 2016
HHS in type 1 diabetes associated with medication overdose: can counter-regulatory hormone suppression prevent diabetic ketoacidosis?
E Ghorani, ML Evans, D Simmons
Practical Diabetes International 2016
Obesity and the dysregulation of fatty acid metabolism: implications for healthy aging
A Morgan, K Mooney, MM Auley
Expert Review of Endocrinology & Metabolism 2016
Endocrinology
C Napier, SH Pearce
Endocrinology 2016
Obesity and Cancer
T Pischon, K Nimptsch
Obesity and Cancer 2016
Mathematical modelling of hepatic lipid metabolism
AC Pratt, JA Wattis, AM Salter
Mathematical Biosciences 2015
Widdrol-induced lipolysis is mediated by PKC and MEK/ERK in 3T3-L1 adipocytes
HY Jeong, HJ Yun, BW Kim, EW Lee, HJ Kwon
Molecular and Cellular Biochemistry 2015
Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
SA Sadry, DJ Drucker
Nature Reviews Endocrinology 2013
Hepatic Steatosis in Type 1 Diabetes
SE Regnell, Å Lernmark
The review of diabetic studies : RDS 2012
Bowels control brain: gut hormones and obesity
BC Field, OB Chaudhri, SR Bloom
Nature Reviews Endocrinology 2010
Food Science and Technology
M Vemuri, D Kelley
Fatty Acids in Foods and their Health Implications,Third Edition 2007
Relationship between fatty acids and the endocrine and neuroendocrine system
SJ Bhathena
Nutritional Neuroscience 2006
Glucagon et glucorégulation
L Tappy
Annales d'Endocrinologie 2004
An etiologic model proposing that non-insulin-dependent diabetes mellitus is chronic hypoxic stress hyperglycemia
KA Schiel
Medical Hypotheses 2002
The Circulating Hormonal Milieu of the Endocrine Pancreas in Healthy Individuals, Organ Donors, and the Isolated Perfused Human Pancreas
FC Brunicardi, Y Dyen, L Brostrom, R Kleinman, J Colonna, H Gelabert, R Gingerich
Pancreas 2000
Relationship between fatty acids and the endocrine system
SJ Bhathena
BioFactors 2000
The Circulating Hormonal Milieu of the Endocrine Pancreas in Healthy Individuals, Organ Donors, and the Isolated Perfused Human Pancreas:
FC Brunicardi, Y Dyen, L Brostrom, R Kleinman, J Colonna, H Gelabert, R Gingerich
Pancreas 2000
Principles of Perinatal—Neonatal Metabolism
RM Cowett
1998
Regulation of fatty-acid metabolism by pancreatic hormones in cultured human hepatocytes
C Vons, JP Pegorier, J Girard, C Kohl, MA Ivanov, D Franco
Hepatology 1991
Effect of stress hormones on transsplanchnic balance of exogenous amino acids in healthy man
K Ratheiser, M Komjati, S Gasic, P Bratusch-Marrain, W Waldhäusl
Metabolism 1991
Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels
JM Romeo, C Novo, A Fernández-Cruz, JM Lòpez-Novoa
Heart and Vessels 1990
The biochemistry of diabetes
R Taylor, L Agius
Biochemical Journal 1988
Effect of β-hydroxybutyrate and acetoacetate on insulin and glucagon secretion from perfused rat pancreas
T Ikeda, T Yoshida, Y Ito, I Murakami, O Mokuda, M Tominaga, H Mashiba
Archives of Biochemistry and Biophysics 1987
Pancreatic hormones in the nonhibernating and hibernating golden mantled ground squirrel
WA Bauman, S Meryn, GL Florant
Comparative Biochemistry and Physiology Part A: Physiology 1987
Effect of somatostatin on renal function
JP Vora, DR Owens, R Ryder, J Atiea, S Luzio, TM Hayes
British medical journal (Clinical research ed.) 1986
Possible roles of insulin, glucagon, growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver diseases
E Bonora, S Orioli, C Coscelli, G Buzzelli, P Gentilini, U Butturini
Acta Diabetologica Latina 1984
Determinants of glucose and ketoacid concentrations in acutely hyperglycemic diabetic patients
CD Malchoff, SL Pohl, DL Kaiser, RM Carey
The American Journal of Medicine 1984
Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man
JM Miles, MW Haymond, SL Nissen, JE Gerich
Journal of Clinical Investigation 1983
Insulin-counteracting hormones: Their impact on glucose metabolism
PR Bratusch-Marrain
Diabetologia 1983
3Glucose and ketone body kinetics in diabetic ketoacidosis
JM Miles, JE Gerich
Clinics in Endocrinology and Metabolism 1983
Glucagon I
PJ Lefèbvre
1983
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy
SD Prato, A Tiengo, U Baccaglini, C Tremolada, E Duner, MC Marescotti, A Avogaro, I Valverde, R Nosadini, R Assan
Diabetologia 1983
Failure of glucagon to stimulate ketone body production during acute insulin deficiency or insulin replacement in man
GE Sonnenberg, W Stauffacher, U Keller
Diabetologia 1982
Ciba Foundation Symposium 87 - Metabolic Acidosis: Ciba/Metabolic
R Porter, G Lawrenson
1982
Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue
GJ Taborsky, D Porte
American journal of physiology. Endocrinology and metabolism 1981
Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects
GE Sonnenberg, U Keller, A Perruchoud, D Burckhardt, K Gyr
Gastroenterology 1981
The acute metabolic effects of glucagon and its interactions with insulin in forearm tissue
SH Schneider, SE Fineberg, GL Blackburn
Diabetologia 1981
The role of ?diabetogenic? hormones on carbohydrate and lipid metabolism following oral glucose loading in insulin dependent diabetics: Effects of acute hormone administration
P Bratusch-Marrain, W Waldhusl, B Grubeck-Loebenstein, A Korn, H Vierhapper, P Nowotny
Diabetologia 1981
The effect of glucagon treatment and starvation of virgin and lactating rats on the rates of oxidation of octanoyl-L-carnitine and octanoate by isolated liver mitochondria
VA Zammit
Biochemical Journal 1980
Roles for insulin and glucagon in the development of ruminant ketosis -- a review
RP Brockman
The Canadian veterinary journal. La revue vétérinaire canadienne 1979
The role of glucagon in the regulation of plasma lipids
DS Schade, W Woodside, RP Eaton
Metabolism 1979
Effect of glucagon on glucose production during insulin deficiency in the dog
AD Cherrington, WW Lacy, JL Chiasson
Journal of Clinical Investigation 1978
Glucagon Effects on Plasma Cyclic AMP and other Reactants in Normals and Low Insulin Responders
B Israelsson, G Fex, J Malmquist, G Nordén
Acta Medica Scandinavica 1978
Metabolic effects of glucagon in endogenous hypertriglyceridemia
R Nosadini, G Soldà, F Biasi, A Tiengo
Acta Diabetologica Latina 1978
Combined deficiency of glucose-6-phosphatase and fructose-1,6-diphosphatase
FJ Service, CM Veneziale, RA Nelson, RD Ellefson, VL Go
The American Journal of Medicine 1978
The Diabetic Pancreas
GF Cahill
New England Journal of Medicine 1978
The Year in Metabolism 1977
N Freinkel
1978
Aktuelle Probleme der Pathobiochemie
H Lang, W Rick, L Róka
1978
HORMONAL AND METABOLIC RESPONSES TO GLUCAGON IN DIABETES MELLITUS
RW Simpson, TD Hockaday, KG Alberti
Clinical Endocrinology 1977
Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man
DS Schade, PR Eaton, I Pommer, R Temple
Acta Diabetologica Latina 1977
Impaired responsiveness to the effect of glucagon on plasma adenosine 3‘:5’-cyclic monophosphate in normal man
GN Hendy, S Tomlinson, JL O'riordan
European Journal of Clinical Investigation 1977
Influence of glucagon on natriuresis and glucose-induced sodium retention in the fasting obese subject
J Kolanowski, G Salvador, P Desmecht, JC Henquin, J Crabbé
European Journal of Clinical Investigation 1977
Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate
P Beck, DE Zimmerman, RP Eaton
Metabolism 1977
8 Diabetic coma: A reappraisal after five years
KG Alberti, TD Hockaday
Clinics in Endocrinology and Metabolism 1977
Ketoacidosis in Pancreatectomized Man
AJ Barnes, SR Bloom, KG Alberti, P Smythe, FP Alford, DJ Chisholm
New England Journal of Medicine 1977
Effects of exogenous glucagon and epinephrine in physiological amounts on the blood levels of free fatty acids and glycerol in dogs
WA Muller, TT Aoki, RH Egdahl, GF Cahill
Diabetologia 1977
Hypothalamic Peptide Hormones and Pituitary Regulation
JC Porter
1977
Metabolic and hormonal effects of muscular exercise in juvenile type diabetics
M Berger, P Berchtold, HJ Cppers, H Drost, HK Kley, WA Mller, W Wiegelmann, H Zimmermann-Telschow, FA Gries, HL Krskemper, H Zimmermann
Diabetologia 1977
Persistent metabolic abnormalities in diabetes in the absence of glucagon.
Barnes AJ, Bloom SR, Mashiter K, Alberti KG, Smythe P, Turnell D
Diabetologia 1977
Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin
JE Gerich, M Lorenzi, DM Bier, E Tsalikian, V Schneider, JH Karam, PH Forsham
Journal of Clinical Investigation 1976
Effects of glucagon and insulin on lipolysis and ketogenesis in sheep
RP Brockman
Canadian journal of comparative medicine. Revue canadienne de médecine comparée 1976
Effects of β-hydroxybutyrate, glycerol, and free fatty acid infusions on glucagon and epinephrine secretion in dogs during acute hypoglycemia
WA Müller, TT Aoki, JP Flatt, GL Blackburn, RH Egdahl, GF Cahill
Metabolism 1976
Glucagon and ketogenesis
JD McGarry, C Robles-Valdes, DW Foster
Metabolism 1976
Pathogenesis, diagnosis and treatment of diabetic ketoacidosis
MD Kogut
Current Problems in Pediatrics 1976
Der Risikopatient in der Anästhesie
FW Ahnefeld, H Bergmann, C Burri, W Dick, M Halmàgyi, E Rügheimer
1976
Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon
J McGarry, PH Wright, DW Foster
Journal of Clinical Investigation 1975
Glucagon regulation of plasma ketone body concentration in human diabetes
DS Schade, RP Eaton
Journal of Clinical Investigation 1975
THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS
RH Unger, L Orci
The Lancet 1975
PATHOGENESIS OF NONKETOTIC HYPEROSMOLAR DIABETIC COMA
BI Joffe, LH Krut, RB Goldberg, HC Seftel
The Lancet 1975
Glucagon and adipose tissue
P Lefebvre
Biochemical Pharmacology 1975
The contribution of endogenous insulin secretion to the ketogenic response to glucagon in man
DS Schade, RP Eaton
Diabetologia 1975
A combined radioimmunoassay for glucagon and insulin
V Leclercq-Meyer, J Marchand, O Rebolledo, WJ Malaisse, R Leclercq
Diabetologia 1975
Effect of Glucagon on Net Splanchnic Cyclic AMP Production in Normal and Diabetic Men
JE Liljenquist, JD Bomboy, SB Lewis, BC Sinclair-Smith, PW Felts, WW Lacy, OB Crofford, GW Liddle
Journal of Clinical Investigation 1974
GLUCAGON CONTROL OF FASTING GLUCOSE IN MAN
FP Alford, SR Bloom, JD Nabarro, R Hall, GM Besser, DH Coy, AJ Kastin, AV Schally
The Lancet 1974

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Posted by 1 X users
Referenced in 5 patents
Referenced in 5 Wikipedia pages
70 readers on Mendeley
1 readers on CiteULike
See more details